Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study

por Yi, Tae Won, Atiquzzaman, Mohammad, Zheng, Yuyan, Smyth, Brendan, Jardine, Meg, Levin, Adeera
Publicado 2022

Anti-Epileptic Medication Exposure Influences Functional Status in New Zealand Stroke Patients: A Retrospective Population-Level Study

por McGregor, Ailsa L., Hoque, Md. Rashedul, Nickel, Sophia, Smith, Alesha J., Atiquzzaman, Mohammad
Publicado 2021

Prescription Pattern of Cation Exchange Resins and Their Efficacy in Treating Chronic Hyperkalemia Among Patients With Chronic Kidney Diseases: Findings From a Population-Based Ana...

por Atiquzzaman, Mohammad, Birks, Peter, Bevilacqua, Micheli, Wong, Michelle M. Y., Zheng, Yuyan, Djurdjev, Ognjenka, Levin, Adeera
Publicado 2022

COVID-19 vaccine effectiveness in patients with non–dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada

por Atiquzzaman, Mohammad, Zheng, Yuyan, Er, Lee, Djurdjev, Ognjenka, Singer, Joel, Krajden, Mel, Balamchi, Shabnam, Thomas, Doneal, Oliver, Matthew J., Levin, Adeera
Publicado 2022

COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces

por Atiquzzaman, Mohammad, Zheng, Yuyan, Er, Lee, Djurdjev, Ognjenka, Singer, Joel, Krajden, Mel, Balamchi, Shabnam, Thomas, Doneal, Hladunewich, Michelle, Oliver, Matthew J, Levin, Adeera
Publicado 2023

Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease

por Naylor, Kyla L., McArthur, Eric, Dixon, Stephanie N., Kwong, Jeffrey C., Thomas, Doneal, Balamchi, Shabnam, Blake, Peter G., Garg, Amit X., Atiquzzaman, Mohammad, Hladunewich, Michelle A., Levin, Adeera, Yeung, Angie, Oliver, Matthew J.
Publicado 2023

Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis

por Yau, Kevin, Chan, Christopher T., Abe, Kento T., Jiang, Yidi, Atiquzzaman, Mohammad, Mullin, Sarah I., Shadowitz, Ellen, Liu, Lisa, Kostadinovic, Ema, Sukovic, Tatjana, Gonzalez, Anny, McGrath-Chong, Margaret E., Oliver, Matthew J., Perl, Jeffrey, Leis, Jerome A., Bolotin, Shelly, Tran, Vanessa, Levin, Adeera, Blake, Peter G., Colwill, Karen, Gingras, Anne-Claude, Hladunewich, Michelle A.
Publicado 2022

Différences d’immunogénicité des vaccins anti-SRAS-CoV-2 mRNA-1273 (Moderna) et BNT162b2 (Pfizer-BioNTech) chez les patients dialysés

por Yau, Kevin, Chan, Christopher T., Abe, Kento T., Jiang, Yidi, Atiquzzaman, Mohammad, Mullin, Sarah I., Shadowitz, Ellen, Liu, Lisa, Kostadinovic, Ema, Sukovic, Tatjana, Gonzalez, Anny, McGrath-Chong, Margaret E., Oliver, Matthew J., Perl, Jeffrey, Leis, Jerome A., Bolotin, Shelly, Tran, Vanessa, Levin, Adeera, Blake, Peter G., Colwill, Karen, Gingras, Anne-Claude, Hladunewich, Michelle A.
Publicado 2022